Skip to main content

Advertisement

Log in

Development, Characterization and Permeability Assessment Based on Caco-2 Monolayers of Self-Microemulsifying Floating Tablets of Tetrahydrocurcumin

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Novel self-microemulsifying floating tablets were developed to enhance the dissolution and oral absorption of the poorly water-soluble tetrahydrocurcumin (THC). Their physicochemical properties and THC permeability across Caco-2 cell monolayers were assessed. The self-microemulsifying liquid containing THC was adsorbed onto colloidal silicon dioxide, mixed with HPMC, gas-generating agents (sodium bicarbonate and tartaric acid), lactose and silicified-microcrystalline cellulose and transformed into tablets by direct compression. The use of different types/concentrations of HPMC and sodium bicarbonate in tablet formulations had different effects on the floating characteristics and in vitro THC release. The optimum tablet formulation (F2) provided a short floating lag time (∼23 s) together with a prolonged buoyancy (>12 h). About 72% of THC was released in 12 h with an emulsion droplet size in aqueous media of 33.9 ± 1.0 nm while that of a self-microemulsifying liquid was 29.9 ± 0.3 nm. The tablet formulation was stable under intermediate and accelerated storage conditions for up to 6 months. The THC released from the self-microemulsifying liquid and tablet formulations provided an approximately three- to fivefold greater permeability across the Caco-2 cell monolayers than the unformulated THC and indicated an enhanced absorption of THC by the formulations. The self-microemulsifying floating tablet could provide a dosage form with the potential to improve the oral bioavailability of THC and other hydrophobic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

REFERENCES

  1. Yoysungnoen P, Wirachwong P, Changtam C, Suksamran A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008;14(13):2003–9.

    Article  PubMed  CAS  Google Scholar 

  2. Murakami Y, Ishii H, Takada N, Tanaka S, Machino M, Ito S, Fujisawa S. Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic O–H bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Anticancer Res. 2008;28(2A):699–707.

    PubMed  CAS  Google Scholar 

  3. Lai CH, Wu JC, Yu SF, Badmaev V, Nagabhushanam K, Ho CH, Pan MH. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. 2011;55(12):1819–28.

    Article  PubMed  CAS  Google Scholar 

  4. Muragan P, Pari L, Rao CA. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. J Biosci. 2008;33(1):63–72.

    Article  Google Scholar 

  5. Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res. 2012;35:418–25.

    Article  PubMed  CAS  Google Scholar 

  6. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral bioavailability of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.

    Article  PubMed  Google Scholar 

  7. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371:148–55.

    Article  PubMed  CAS  Google Scholar 

  8. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010;383:1–6.

    Article  PubMed  CAS  Google Scholar 

  9. Zvonar A, Gasperlin M. Microcapsules with self-emulsifying core: optimization of shell-forming phase. Pharmazie. 2010;65:391–2.

    PubMed  CAS  Google Scholar 

  10. Abdalla A, Mäder K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220–6.

    Article  PubMed  CAS  Google Scholar 

  11. Setthacheewakul S, Kedjinda W, Maneenuan D, Wiwattanapatapee R. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). AAPS PharmSciTech. 2010;12(1):152–64.

    Article  PubMed  Google Scholar 

  12. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240:103–14.

    Article  PubMed  CAS  Google Scholar 

  13. Elkheshen SA, Yassin AEB, Alsuwayeh S, Alkhaled FA. In vitro and in vivo evaluation of floating controlled release dosage forms of verapamil hydrochloride. Pharm Ind. 2004;66(11):1364–72.

    CAS  Google Scholar 

  14. Chen RN, Ho HO, Yu CY, Sheu MT. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism. Eur J Pharm Biopharm. 2010;39:82–9.

    CAS  Google Scholar 

  15. Zhao L, Yang X, Xu R, Wu J, Gu S, Zhang L, Gong P, Chen H, Zang F. Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects. Int J Pharm. 2009;377:99–104.

    Article  PubMed  CAS  Google Scholar 

  16. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005;6(3):E372–90.

    Article  PubMed  Google Scholar 

  17. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235–59.

    Article  PubMed  CAS  Google Scholar 

  18. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee LI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG. Enhanced oral boioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009;374:66–72.

    Article  PubMed  CAS  Google Scholar 

  19. Motz SA, Schaefer UF, Balbach S, Eichinger T, Lehr CM. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. Eur J Pharm Biopharm. 2007;66:286–95.

    Article  PubMed  CAS  Google Scholar 

  20. Rao SV, Agarwal P, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In vitro transport study. Int J Pharm. 2008;362:10–5.

    Article  PubMed  CAS  Google Scholar 

  21. Zvonar A, Berginc K, Kristl A, Gašperlin M. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm. 2010;388:151–8.

    Article  PubMed  CAS  Google Scholar 

  22. Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm. 2008;362:118–25.

    Article  PubMed  CAS  Google Scholar 

  23. Strübing S, Abboud T, Contri RV, Metz H, Mäder K. New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm. 2008;69:708–17.

    Article  PubMed  Google Scholar 

  24. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139–57.

    Article  PubMed  CAS  Google Scholar 

  25. Liang WQ, Chow MSS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release. 2004;95:209–16.

    Article  PubMed  Google Scholar 

  26. Conti S, Maggi L, Segale L, Machisre OM, Conte U, Grenier P, Vergnault G. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int J Pharm. 2007;333:136–42.

    Article  PubMed  CAS  Google Scholar 

  27. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm. 2011;77:275–82.

    Article  PubMed  CAS  Google Scholar 

  28. Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2(9):2111–9.

    Article  PubMed  CAS  Google Scholar 

  29. Wade A, Weller PJ. Handbook of pharmaceutical excipients. 2nd ed. Washington: American Pharmaceutical Association; 1994.

    Google Scholar 

  30. Gohel MC. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 2005;8(1):76–93.

    PubMed  CAS  Google Scholar 

  31. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 2000;3(2):58–63.

    Article  PubMed  CAS  Google Scholar 

  32. Arza RAK, Gonugunta CSR, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10(1):220–6.

    Article  PubMed  CAS  Google Scholar 

  33. Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74:332–9.

    Article  PubMed  CAS  Google Scholar 

  34. Martínez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int J Pharm. 2008;362:37–43.

    Article  Google Scholar 

  35. Scherließ R. The MTT assay as tool to evaluate and compare excipient toxicity in vitro on respiratory epithelial cells. Int J Pharm. 2011;411:98–105.

    Article  PubMed  Google Scholar 

  36. Kogan A, Kesselman E, Danino D, Aserin A, Garti N. Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions. Colloids Surf B. 2008;66:1–12.

    Article  CAS  Google Scholar 

  37. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth. Pharm Res. 1997;14:763–6.

    Article  PubMed  CAS  Google Scholar 

Download references

ACKNOWLEDGEMENTS

Financial support was granted by the Thailand Research Fund under the Royal Golden Jubilee Ph.D. programme (PHD/0080/2551) and the Royal Thai Government through Prince of Songkla University (PHA540093S). We also wish to thank Dr. Brian Hodgson for assistance with the English.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruedeekorn Wiwattanapatapee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sermkaew, N., Wiwattanawongsa, K., Ketjinda, W. et al. Development, Characterization and Permeability Assessment Based on Caco-2 Monolayers of Self-Microemulsifying Floating Tablets of Tetrahydrocurcumin. AAPS PharmSciTech 14, 321–331 (2013). https://doi.org/10.1208/s12249-012-9912-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-012-9912-2

KEY WORDS

Navigation